Dr. Connie Huey Lin, MD

Dr. Lin practices at UCLA Medical Plaza in Santa Monica, California.

Dr. Lin's NPI, 1760825590, was assigned on April 11, 2013. Dr. Lin graduated from UC Irvine School of Medicine in 2013. Dr. Lin holds California license A135421.

Dr. Lin's primary practice is UCLA Medical Plaza, at 1245 16th St, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 794-1276.

Dr. Lin's primary practice is UCLA Medical Plaza in Santa Monica, California. Dr. Lin is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. Lin to 2 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 5 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Lin is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dr. Lin is licensed in California.

CMS data shows 74 Medicare services from Dr. Lin across 4 procedure codes in 2024, for 60 Medicare patients. Medicare paid $7,840 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high cholesterol, and 67% have high blood pressure. 27% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 42, with 65% women.

In 2024, Dr. Lin wrote 298 Medicare Part D claims for 106 patients. 71% of them were for generic drugs. CMS names the drug for 206 of them, across 8 drugs with 11 or more claims each, at $48,353 in total drug cost. In 2023, CMS named 184 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Lin for performance year 2024, reported as part of a group. Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth.

Dmand AI links 4 papers to Dr. Lin in 2022. The most frequent topics are Electric Impedance. Dr. Lin's most frequent co-authors are Daniel Albert Cerrone, MD, Basil T. Darras, MD and Seward Brian Rutkove, MD.

CMS Open Payments shows 17 general payments to Dr. Lin from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 46% of the total. Sanofi and Genzyme US Companies paid the most, $767.

Dr. Lin graduated from UC Irvine School of Medicine in 2013.

Dr. Lin is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.